Wikidata

(Q72472826)

English

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

scientific article published on 01 June 1994

In more languages
default for all languages
No label defined

No description defined

Statements

title
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8196140
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8196140 AND SRC:MED&resulttype=core&format=json
retrieved
26 October 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q72472826&oldid=2228421634"